Schedule of ordinary shares subject to redemption |
Schedule of ordinary shares subject to redemption | |
| | |
Gross proceeds | |
$ | 55,950,000 | |
Less: | |
| | |
Proceeds allocated to public rights | |
| (6,461,922 | ) |
Offering costs allocated to redeemable shares | |
| (1,156,982 | ) |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 517,668 | |
Ordinary shares subject to possible redemption as of June 30, 2025 (Unaudited) | |
$ | 48,848,764 | |
|
Schedule of determination of the fair value of the over-allotment liability |
Schedule of determination of the fair value of the over-allotment liability | |
| | | |
| |
| |
| | | |
| | | |
| | | |
| | |
Valuation date | |
No. of options | | |
Vesting date | |
Expiry date | |
Exercise price | | |
Spot price | | |
Risk-free rate | | |
Volatility | |
May 30, 2025 | |
| 155,000 | | |
May 29, 2025 | |
July 13, 2025 | |
| 9.80 | | |
| 10.01 | | |
| 4.19 | % | |
| 3.4 | % |
June 30, 2025 | |
| 155,000 | | |
May 29, 2025 | |
July 13, 2025 | |
| 9.80 | | |
| 10.09 | | |
| 4.17 | % | |
| 3.1 | % |
|
Schedule of Net income (loss) used in the calculation of basic and dilute EPS |
Schedule
of Net income (loss) used in the calculation of basic and dilute EPS | |
| | |
| |
| |
For the
Three Months Ended June 30, 2025 | | |
For the Six Months Ended June 30, 2025 | |
| |
(Unaudited) | | |
(Unaudited) | |
Net income | |
$ | 113,309 | | |
$ | 38,152 | |
Less: Accretion of redeemable ordinary shares to redemption value | |
| 517,668 | | |
| 517,668 | |
Net loss including accretion of redeemable ordinary shares to redemption value | |
| (404,359 | ) | |
| (479,516 | ) |
|
Schedule of unaudited condensed statement of operations and comprehensive income |
Schedule of unaudited condensed statement of operations and comprehensive
income | |
| | | |
| | | |
| | | |
| | |
| |
For the
Three Months Ended June 30, 2025 | | |
For the
Six Months Ended June 30, 2025 | |
| |
Redeemable Ordinary Share | | |
Non-Redeemable Ordinary Share | | |
Redeemable Ordinary Share | | |
Non-Redeemable Ordinary Share | |
| |
(Unaudited) | | |
(Unaudited) | |
Numerators: | |
| | | |
| | | |
| | | |
| | |
Allocation of net loss | |
$ | (233,655 | ) | |
$ | (170,704 | ) | |
$ | (201,545 | ) | |
$ | (277,971 | ) |
Accretion of redeemable ordinary shares to redemption value | |
| 517,668 | | |
| - | | |
| 517,668 | | |
| - | |
Allocation of net income (loss) | |
$ | 284,013 | | |
$ | (170,704 | ) | |
$ | 316,123 | | |
$ | (277,971 | ) |
Denominators: | |
| | | |
| | | |
| | | |
| | |
Weighted-average ordinary shares outstanding | |
| 1,927,167 | | |
| 1,407,954 | | |
| 963,583 | | |
| 1,328,977 | |
| |
| | | |
| | | |
| | | |
| | |
Basic earnings (loss) per share | |
$ | 0.15 | | |
$ | (0.12 | ) | |
$ | 0.33 | | |
$ | (0.21 | ) |
Net income (loss) used in the calculation of diluted EPS is based on the following:
| |
| | | |
| | |
| |
For the
Three Months Ended June 30, 2025 | | |
For the Six Months Ended June 30, 2025 | |
| |
(Unaudited) | | |
(Unaudited) | |
Net income | |
$ | 113,309 | | |
$ | 38,152 | |
Less: Accretion of redeemable ordinary shares to redemption value | |
| 517,668 | | |
| 517,668 | |
Less: accretion of ordinary share subject to redemption value of participating securities considered potentially dilutive | |
| 12,163 | | |
| 12,163 | |
Net loss including accretion of redeemable ordinary shares to redemption value | |
| (416,522 | ) | |
| (491,679 | ) |
Diluted EPS per share presented in the unaudited condensed statement of operations and comprehensive
income is based on the following:
| |
| | | |
| | | |
| | | |
| | |
| |
For the
Three Months Ended June 30, 2025 | | |
For the
Six Months Ended June 30, 2025 | |
| |
Redeemable Ordinary Share | | |
Non-Redeemable Ordinary Share | | |
Redeemable Ordinary Share | | |
Non-Redeemable Ordinary Share | |
| |
(Unaudited) | | |
(Unaudited) | |
Numerators: | |
| | | |
| | | |
| | | |
| | |
Allocation of net loss | |
$ | (243,454 | ) | |
$ | (173,068 | ) | |
$ | (209,938 | ) | |
$ | (281,742 | ) |
Accretion of redeemable ordinary shares to redemption value | |
| 529,831 | | |
| - | | |
| 529,831 | | |
| - | |
Allocation of net income (loss) | |
$ | 286,377 | | |
$ | (173,068 | ) | |
$ | 319,894 | | |
$ | (281,742 | ) |
Denominators: | |
| | | |
| | | |
| | | |
| | |
Weighted-average ordinary shares outstanding | |
| 1,980,556 | | |
| 1,407,954 | | |
| 990,278 | | |
| 1,328,977 | |
| |
| | | |
| | | |
| | | |
| | |
Diluted earnings (loss) per share | |
$ | 0.14 | | |
$ | (0.12 | ) | |
$ | 0.32 | | |
$ | (0.21 | ) |
|